132 related articles for article (PubMed ID: 37210977)
1. Pericardial Fluid Analysis in Diagnosis and Prognosis of Patients Who Underwent Pericardiocentesis.
Sullivan A; Dennis ASC; Rathod K; Jones D; Rosmini S; Manisty C; Bhattacharyya S; Foggo V; Conibear J; Koh T; Rees P; Ozkor M; Thornton CC; O'Mahony C
Am J Cardiol; 2023 Jul; 198():79-87. PubMed ID: 37210977
[TBL] [Abstract][Full Text] [Related]
2. Malignant pericardial effusions: A retrospective look at etiology and prognosis in a tertiary oncological center.
Quirk T; Yao Y; Sverdlov A; Murch S
Asia Pac J Clin Oncol; 2023 Aug; 19(4):468-472. PubMed ID: 35950292
[TBL] [Abstract][Full Text] [Related]
3. Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis.
Strobbe A; Adriaenssens T; Bennett J; Dubois C; Desmet W; McCutcheon K; Van Cleemput J; Sinnaeve PR
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29275375
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion.
Karatolios K; Pankuweit S; Maisch B
Heart Fail Rev; 2013 May; 18(3):337-44. PubMed ID: 22638889
[TBL] [Abstract][Full Text] [Related]
5. Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion.
Nakamura T; Okune M; Yasuda M; Watanabe H; Ueno M; Yamaji K; Mizutani K; Kurita T; Nakazawa G
BMC Cardiovasc Disord; 2021 Jun; 21(1):272. PubMed ID: 34082695
[TBL] [Abstract][Full Text] [Related]
6. Causes and prognosis of symptomatic pericardial effusions treated by pericardiocentesis in an Asian academic medical centre.
Cheong XP; Law LKP; Seow SC; Tay LWE; Tan HC; Yeo WT; Low AF; Kojodjojo P
Singapore Med J; 2020 Mar; 61(3):137-141. PubMed ID: 32488274
[TBL] [Abstract][Full Text] [Related]
7. Safety and Outcome of Percutaneous Drainage of Pericardial Effusions in Patients with Cancer.
Lekhakul A; Assawakawintip C; Fenstad ER; Pislaru SV; Thaden JJ; Sinak LJ; Kane GC
Am J Cardiol; 2018 Sep; 122(6):1091-1094. PubMed ID: 30064854
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers in the assessment of malignant and benign pericardial effusion].
Karatolios K; Maisch B; Pankuweit S
Herz; 2011 Jun; 36(4):290-5. PubMed ID: 21491120
[TBL] [Abstract][Full Text] [Related]
9. Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy.
Campbell PT; Van Trigt P; Wall TC; Kenney RT; O'Connor CM; Sheikh KH; Kisslo JA; Baker ME; Corey GR
Chest; 1992 Apr; 101(4):938-43. PubMed ID: 1555467
[TBL] [Abstract][Full Text] [Related]
10. Differential Impact of Constrictive Physiology after Pericardiocentesis in Malignancy Patients with Pericardial Effusion.
Cho IJ; Chang HJ; Chung H; Lee SE; Shim CY; Hong GR; Ha JW; Chung N
PLoS One; 2015; 10(12):e0145461. PubMed ID: 26691279
[TBL] [Abstract][Full Text] [Related]
11. The efficiency of surgical subxiphoid pericardial drainage and percutaneous pericardial drainage in pericardial effusions associated with cardiac tamponade.
Petcu CP; Droc I
Chirurgia (Bucur); 2013; 108(2):226-33. PubMed ID: 23618573
[TBL] [Abstract][Full Text] [Related]
12. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors.
Palaskas N; Morgan J; Daigle T; Banchs J; Durand JB; Hong D; Naing A; Le H; Hassan SA; Karimzad K; Mouhayar E; Kim P; Lopez-Mattei J; Thompson K; Yusuf SW; Iliescu C
Am J Cardiol; 2019 Apr; 123(8):1351-1357. PubMed ID: 30765065
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion.
Sezenöz B; Uyar Göçün FP; Kızıltunç E; Topal S; Özdemir HM
Anatol J Cardiol; 2023 Jan; 27(1):41-46. PubMed ID: 36680446
[TBL] [Abstract][Full Text] [Related]
14. Operation for diagnosis and treatment of pericardial effusions.
Little AG; Kremser PC; Wade JL; Levett JM; DeMeester TR; Skinner DB
Surgery; 1984 Oct; 96(4):738-44. PubMed ID: 6207601
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion.
El Haddad D; Iliescu C; Yusuf SW; William WN; Khair TH; Song J; Mouhayar EN
J Am Coll Cardiol; 2015 Sep; 66(10):1119-28. PubMed ID: 26337990
[TBL] [Abstract][Full Text] [Related]
16. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage.
Fenstad ER; Le RJ; Sinak LJ; Maradit-Kremers H; Ammash NM; Ayalew AM; Villarraga HR; Oh JK; Frantz RP; McCully RB; McGoon MD; Kane GC
Chest; 2013 Nov; 144(5):1530-1538. PubMed ID: 23949692
[TBL] [Abstract][Full Text] [Related]
17. Is malignancy associated with pericardial effusion fluid volume or fluid character?
Yeşiltaş MA; Koyuncu AO; Haberal İ; Yilmaz Ak H; Özsoy SD; Sayili U; Kuserli Y
J Card Surg; 2020 Oct; 35(10):2583-2588. PubMed ID: 32668050
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion.
Gornik HL; Gerhard-Herman M; Beckman JA
J Clin Oncol; 2005 Aug; 23(22):5211-6. PubMed ID: 16051963
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis.
Ben-Horin S; Bank I; Shinfeld A; Kachel E; Guetta V; Livneh A
Am J Cardiol; 2007 May; 99(9):1294-7. PubMed ID: 17478160
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Outcomes of Pericardiocentesis Versus Surgical Pericardial Window in Patients Requiring Drainage of Pericardial Effusions.
Horr SE; Mentias A; Houghtaling PL; Toth AJ; Blackstone EH; Johnston DR; Klein AL
Am J Cardiol; 2017 Sep; 120(5):883-890. PubMed ID: 28739031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
